Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZB30 vs Gonal-f Bioequivalence Study
NCT06778304Phase 1Completed
- Sponsor
- West China Second University Hospital
- Start
- Jan 2021
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of recombinant human follicle-stimulating hormone (JZB30) in infertility, sponsored by West China Second University Hospital. Primary endpoint: Area Under the Curve at 168 hours. Started Jan 2021; status: completed.
02
Drugs
recombinant human follicle-stimulating hormone (JZB30)
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06778304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06778304.